-
17-year-old girl suffering from rheumatology, limb joint deformation can not walk! Doctor: Be alert to these symptoms
Time of Update: 2021-01-18
3-year-old illness Listen to the letter side missed the best treatment time" listen to my mother said, I was 3 years old, the first is the right ankle unprovoked swelling, bulging a big bag, and then one by one spread to the hands and feet joint.
-
The European Medicines Agency has approved Zeposia (ozanimod) for the treatment of ulcerative colitis
Time of Update: 2021-01-18
MAA presented to the EMA is based on the results of the True North study, a critical, placebo-controlled Phase III clinical trial designed to evaluate Zeposia as an induction and maintenance therapy for moderate to severe active UC.
-
New anti-inflammatory drugs! AbbVie IL-23 inhibitor Skyrizi treats psoriasis arthritis 2 Phase III studies have been successful!
Time of Update: 2021-01-18
January 07, 2021 // -- AbbVie recently announced positive topline results for two Phase 3 studies (KEEPsAKE-1 and KEEPsAKE-2) evaluating the treatment of active psoriasis arthritis (PsA) adult patients with the new anti-inflammatory drug IL-23 inhibitor Skyrizi (risankizumab).
-
Scientists have shown for the first time that complex tissue can be safely reprogrammed into a younger form...
Time of Update: 2021-01-06
clinical studies have confirmed that exosomes play an anti-aging role in the skin, and that the consequence of aging is a decrease in tissue regeneration potential, which may reflect a decrease in the number of skin stem cells or a decrease in their function.
-
"Medical Headline Jun" has just been established for a month (Viatris) is going to be laid off again...
Time of Update: 2021-01-05
. 2020 lung cancer field heavy research summary; in the second half of 2020 8 enterprises staged the annual "eat melon drama"; big open: only sell Class B OTC on the same day to close the certificate; MNC's PD-1 "Game of Thrones" climax has just begun ...
-
Real case: CAR-T
Time of Update: 2021-01-04
Part 01 disappears from lymphoma to cancer cells, CAR-T immunotherapy saves happy families "and this is our best Christmas present of the year, and hopefully more people will be able to take this new treatment in the future." " - On Christmas Eve 2018, a British woman, HelenSus, was told by doctors that an ultrasound had revealed a grapefruit-sized lump in her chest.
-
Reding Pharmaceuticals and Cullinan Oncology on CLN-0...
Time of Update: 2021-01-04
Reding Pharmaceuticals (NASDAQ: ZLAB; Hong Kong Stock Exchange: 9688) and Cullinan Oncology announced that they have reached an exclusive authorized partnership to advance the development, production and commercialization of CLN-081 in Greater China.
-
11 trends in the biopharmaceutical industry in 2020
Time of Update: 2021-01-04
bioprocessing facilities for many of the new pandemic-related products will be highly automated, requiring only automation to achieve the required capacity and reduce costs and time-to-market.
-
Can the Mediterranean diet really improve human health? Look at the results!
Time of Update: 2021-01-04
researchers say the beneficial effects of the Mediterranean diet may be related to its high levels of polyphenols, healthy fat and fiber intake, and low levels of animal protein intake; researchers want to study whether the green version of the diet is more beneficial to the body's health, i.e. more sources of green plant food and lower levels of red meat.
-
Johnson amivantamab EU application for listing: treatment of EGFR exoded...
Time of Update: 2021-01-04
Johnson and Johnson (JNJ) Janssen Pharmaceuticals recently announced that it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) seeking approval for Amivantamab (JNJ-61186372, JNJ -6372), used to treat patients with metastasis non-small cell lung cancer (NSCLC) with insertion mutations in exons No. 20 of the skin growth factor acceptor (EGFR) gene after failure to undergo platinum-containing chemotherapy.
-
Vidicyto monoantigen resistance is recognized as a breakthrough treatment for CDE
Time of Update: 2021-01-04
Vedisito monoantigen with the clinical data obtained by CDE awarded breakthrough therapy, the clinical development and registration process in China will undoubtedly be greatly accelerated, is expected to fill the HER2 positive urethra skin cancer clinical treatment gap.
-
Korsuva, an opioid-infested (KOR) excitant, is on the market!
Time of Update: 2021-01-04
recently, the company announced that it had submitted a new drug application (NDA) for Korsuva (CR845, difelikefalin) injections to the U.S. Food and Drug Administration (FDA) to treat moderate to severe itching in patients with hemodialysis.
-
Novartis has announced that a new drug for allergic conjunctivitis has been officially approved in China
Time of Update: 2021-01-04
Pataday as an upgraded version of olotatad eye drops hydrochloric acid, while continuing to maintain dual-acting anti-sensitivity, will also use the frequency of reduction, is conducive to improving treatment compliance, and further standardize the management of patient self-medication.
-
Baishi Meishi Guibao oral S1P subject regulator Zeposia EU application for new...
Time of Update: 2021-01-04
"TRUE NORTH is a multi-center, randomized, double-blind, placebo-controlled Phase III trial that investigates the efficacy and safety of Zeposia 1mg in moderate to severe UC patients who did not respond well to previous treatments.
-
Fosun Pharma's small molecule innovation drug Su ® into the national health insurance directory
Time of Update: 2021-01-04
Among them, Fosun Pharma licensed the introduction of a small molecular innovation drug for the treatment of adult patients with chronic liver disease (CLD)-related plateroid reduction in selected-line diagnostic operations or surgery - Sukehin® (Malay acid Avalepopa tablets) was formally included in the national health insurance directory through negotiations.
-
Several articles focus on new achievements made by scientists in the field of melatonin research in recent years!
Time of Update: 2021-01-04
Doi:10.1111/jpi.12693 In a recent study published in the international journal Journal of Pineal Research, scientists from Brazil and the United States used the study to describe a group of genes that are potentially regulated by melatonin in certain cancer types, especially breast cancer, and the results may be used to help develop new, individualized therapies for the treatment of diseases.
-
Nature: Significant progress! The new IspH inhibitor molecule kills a range of Gloran-negative bacteria and quickly activates the host's immune response
Time of Update: 2021-01-03
DECEMBER 27, 2020 /--- In a new study, researchers from the Westa Institute in the United States have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan-resistant bacterial pathogens with the rapid immune response needed to fight antimicrobial resistance (AMR).
-
Latest Research Advances in Hematopoietic Stem Cells (No. 7)
Time of Update: 2021-01-03
2.Cell Rep: Scientists have developed a new method or energy source to produce hematopoietic stem cells doi:10.1016/j.celrep.2020.108474 In a study published in the international journal Cell Reports, scientists from institutions such as the Spanish Genome Control Center and Columbia University identified a special protein that is critical to the expansion of scarce, life-saving hematopoietic stem cells (HSC).
-
Progress on HIV research in December 2020
Time of Update: 2021-01-03
Based on a study published December 3, 2020 in the journal PLOS Pathogens, Dr. Nicole Klatt of the University of Minnesota School of Medicine and colleagues found that this imbalance may lead to the metabolism of bacteria in drugs designed to prevent HIV infection, thereby reducing their effectiveness and increasing the risk to women.
-
NEJM and medRxiv: Two new studies show that people infected with the new coronavirus have a smaller risk of re-infection, but still need to be protected and not taken lightly
Time of Update: 2021-01-03
the results were published in the medRxiv preprint server and the NEJM journal under the titles "Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a developed risk of ion" and "Antibody Status and Agents of SARS-CoV-2 Infected in Health Care Care".